Cover Image
市場調查報告書

甲一型抗胰蛋白酵素缺乏症:全球臨床實驗檢討

Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 242624
出版日期 內容資訊 英文 79 Pages
訂單完成後即時交付
價格
Back to Top
甲一型抗胰蛋白酵素缺乏症:全球臨床實驗檢討 Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H1, 2015
出版日期: 2015年01月31日 內容資訊: 英文 79 Pages
簡介

本報告提供全球甲一型抗胰蛋白酵素缺乏症治療藥物臨床實驗相關調查,各地區臨床實驗數資料,實驗階段,實驗狀況,採用主題及各類型贊助企業的臨床實驗資料,中斷(暫時停止,廢止,停止)的實驗清單等資料,為您概述為以下內容。

目錄

  • 表格一覽
  • 圖表一覽
  • 簡介
  • 甲一型抗胰蛋白酵素缺乏症
  • 報告指南
  • 臨床實驗 , 各地區
  • 臨床實驗 , 各國
  • 對臨床實驗有所貢獻的主要國家 - 亞太地區
  • 對臨床實驗有所貢獻的主要國家 - 歐洲
  • 對臨床實驗有所貢獻的主要國家 - 北美
  • 對臨床實驗有所貢獻的主要國家 - 中南美
  • 臨床實驗 G7 各國
  • 臨床實驗 - G7 各國 , 各臨床實驗狀態
  • 各階段臨床實驗
  • 進行中的臨床實驗 各階段
  • 臨床實驗 , 各臨床實驗狀態
  • 未完成的臨床實驗; 甲一型抗胰蛋白酵素缺乏症
  • 每段時期的實驗人數
  • 有力的贊助商
  • 參加主要企業 - 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗
  • 潛力治療藥物比較
  • 臨床實驗簡介
  • 臨床實驗概要; 主要企業
  • Baxter International Inc.
  • 臨床實驗概要; Baxter International Inc.
  • Talecris Biotherapeutics Holdings Corp
  • 臨床實驗概要; Talecris Biotherapeutics Holdings Corp
  • F. Hoffmann-La Roche Ltd.
  • 臨床實驗概要; F. Hoffmann-La Roche Ltd.
  • 臨床實驗概要; 最高級大學 / 研究機關 / 醫院
  • University ofMassachusetts
  • 臨床實驗概要; University ofMassachusetts
  • University ofFlorida
  • 臨床實驗概要; University ofFlorida
  • The University ofNorth Carolina
  • 臨床實驗概要; The University ofNorth Carolina
  • Medical University ofSouth Carolina
  • 臨床實驗概要; Medical University ofSouth Carolina
  • Assistance Publique - Hopitaux de Paris
  • 臨床實驗概要; Assistance Publique - Hopitaux de Paris
  • University ofPittsburgh
  • 臨床實驗概要; University ofPittsburgh
  • Five 主要 臨床簡介

附錄

  • 簡稱
  • 調查方法
  • 二級研究
  • About GlobalData
  • 諮詢方式
  • 免責聲明
  • 資訊來源

表格一覽

表格一覽

  • 甲一型抗胰蛋白酵素缺乏症 治療藥物市場, 全球市場, 臨床實驗 各地區
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物市場, 全球市場, 臨床實驗 , 各國排名
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物市場, 全球市場, 進行中的臨床實驗 , 各國排名
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗, 亞太地區, 主要國家
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗, 歐洲, 主要國家
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗, 北美, 主要國家
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗, 中南美, 主要國家
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗, G7 各國
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物市場, G7 各國, 臨床實驗 , 各臨床實驗狀態
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物市場, 全球市場, 各階段臨床實驗
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物市場, 全球市場, 進行中的臨床實驗 各階段
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物市場, 全球市場, 臨床實驗 , 各臨床實驗狀態
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物市場, 全球市場, 終止的臨床實驗
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗, 全球市場, 平均登計對象人數趨勢
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗, 全球市場, 主要的贊助商
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗, 全球市場, 主要企業 各階段
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗, 全球市場, 臨床實驗, 各有潛力治療藥
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗 Market, 全球市場, 臨床實驗 - Baxter International Inc.
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗 Market, 全球市場, 臨床實驗 - Talecris Biotherapeutics Holdings Corp
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗 Market, 全球市場, 臨床實驗 - F. Hoffmann-La Roche Ltd.
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗 Market, 全球市場, 臨床實驗 - University ofMassachusetts
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗 Market, 全球市場, 臨床實驗 - University ofFlorida
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗 Market, 全球市場, 臨床實驗 - The University ofNorth Carolina
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗 Market, 全球市場, 臨床實驗 - Medical University ofSouth Carolina
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗 Market, 全球市場, 臨床實驗 - Assistance Publique - Hopitaux de Paris
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗 Market, 全球市場, 臨床實驗 - University ofPittsburgh

圖表一覽

圖表一覽

  • 甲一型抗胰蛋白酵素缺乏症 治療藥物市場, 全球市場, 臨床實驗 各地區 (%)
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物市場, 全球市場, 臨床實驗 , 各國排名
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物市場, 全球市場, 進行中的臨床實驗 , 各國排名
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗, 亞太地區, 主要國家 (%)
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗, 歐洲, 主要國家 (%)
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗, 北美, 主要國家 (%)
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗, 中南美, 主要國家 (%)
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗, G7 各國 (%)
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物市場, G7 各國, 臨床實驗 , 各臨床實驗狀態
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物市場, 全球市場, 各階段臨床實驗 (%)
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物市場, 全球市場, 進行中的臨床實驗 各階段
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物市場, 全球市場, 臨床實驗 , 各臨床實驗狀態
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗, 全球市場, 平均登計對象人數趨勢
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗, 全球市場, 主要的贊助商
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗, 全球市場, 主要企業 各階段
  • 甲一型抗胰蛋白酵素缺乏症 治療藥物的臨床實驗, 全球市場, 臨床實驗, 各有潛力治療藥
  • GlobalData 調查方法

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2548CTIDB

GlobalData's clinical trial report, "Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H1, 2015" provides data on the Alpha- Antitrypsin Deficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Alpha- Antitrypsin Deficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Alpha- Antitrypsin Deficiency. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Alpha- Antitrypsin Deficiency
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Alpha- Antitrypsin Deficiency
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Alpha- Antitrypsin Deficiency
      • Jan 07, 2015: Kamada Reports Encouraging Discussions with European Co-Rapporteurs Regarding European Filing for Inhaled Alpha-1 Antitrypsin to Treat AATD
      • Nov 18, 2014: Arrowhead Files For Regulatory Permission To Begin Phase 1 Trial Of RNAi Therapeutic ARC-AAT
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Grifols, S.A.
      • Clinical Trial Overview of Grifols, S.A.
      • Baxter International Inc.
      • Clinical Trial Overview of Baxter International Inc.
      • Kamada Ltd.
      • Clinical Trial Overview of Kamada Ltd.
      • CSL Limited
      • Clinical Trial Overview of CSL Limited
      • Applied Genetic Technologies Corporation
      • Clinical Trial Overview of Applied Genetic Technologies Corporation
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Arrowhead Research Corporation
      • Clinical Trial Overview of Arrowhead Research Corporation
    • Clinical Trial Overview of Top Institutes / Government
      • Hospices Civils de Lyon
      • Clinical Trial Overview of Hospices Civils de Lyon
      • University of Pittsburgh
      • Clinical Trial Overview of University of Pittsburgh
      • University of Massachusetts Worcester Campus
      • Clinical Trial Overview of University of Massachusetts Worcester Campus
      • Alpha-1 Foundation
      • Clinical Trial Overview of Alpha-1 Foundation
      • University of Massachusetts
      • Clinical Trial Overview of University of Massachusetts
      • Weill Cornell Medical College
      • Clinical Trial Overview of Weill Cornell Medical College
      • University of Miami
      • Clinical Trial Overview of University of Miami
      • University of Florida
      • Clinical Trial Overview of University of Florida
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Region, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials, G7 Countries (%), 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials, E7 Countries (%), 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols, S.A., 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Kamada Ltd., 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Applied Genetic Technologies Corporation, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Arrowhead Research Corporation, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospices Civils de Lyon, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts Worcester Campus, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Alpha-1 Foundation, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2015*

List of Figures

  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials, G7 Countries (%), 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials, E7 Countries (%), 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top